not used title
not used title
Value-based programs between biopharmaceutical companies and pharmacy benefit manager Express Scripts saved $4.3 billion on medicines last year. Patients in these plans with innovative contracting arrangements taking cholesterol-lowering medicines saved nearly $800,000 out of pocket.
In these arrangements, biopharmaceutical companies agree to take on more risk and be reimbursed based on how well medicines work for patients. This can lead to lower copays and coinsurance for patients, allowing them to access the right treatments the first time.
In addition to out-of-pocket savings, patients also saw the benefits of improved care coordination from these innovative contracting arrangements, which included over 100 different medicines. For example, multiple sclerosis patients, for whom adherence is critical, had an average adherence rate of nearly 85% where an innovative contract was in place, compared to an average adherence rate of 25% among all individuals with MS. All Express Scripts plans that used innovative contracting arrangements saw better care and lower spending compared to plans without innovative contracting in every participating therapeutic class.
This adds to growing evidence that innovative contracts can lower out-of-pocket costs and enable patients to access the right treatments the first time. To learn more, visit www.phrma.org/value-collaborative.
Katie Koziara
Katie Koziara is Senior Director of public affairs at PhRMA focusing on the organization’s executive visibility work and media relations strategy. She previously ran the social media strategy for a D.C.-based non-profit working on federal management and leadership issues. Katie earned her B.A. in Public Policy from the University of Michigan’s Ford School and is currently earning her M.A. in Fiction Writing from Johns Hopkins University.
Katie Koziara
Delivering breakthroughs and lower costs for patients
September 8, 2025
The hidden cost of 340B: A multi-billion-dollar burden on taxpayers and Medicaid
July 14, 2025
Ensuring access to affordable medicines for patients through Medicaid
April 28, 2025
Health care practitioners sound the alarm on middlemen-imposed barriers to patient care, need for policy change
March 13, 2025
CMS, don’t fall behind the rest of the medical community on obesity
February 14, 2025
The real cost of denying access to medicines in Medicaid
February 12, 2025
Reimagining patient access through meaningful policy reform
November 5, 2024
New PES survey: Out-of-pocket costs lead key health care priorities ahead of the November election
October 30, 2024
Don’t put the government between patients and their medicines
August 7, 2024
Three things to know about the United Nations’ new HIV/AIDS report
July 31, 2024
Medicaid by the numbers
July 30, 2024
Case study: How seniors could face access disruptions because of the IRA’s price setting provisions
July 22, 2024
The IRA could lead to higher out-of-pocket costs for 3.5 million Medicare patients in 2026
June 25, 2024
ICYMI: Misaligned policies undermine patient access
June 6, 2024
Ongoing federal probes shed light on PBM and insurer practices
May 20, 2024
WTAS: The consequences of consolidation and vertical integration
May 6, 2024
Providing affordable access to medicines in Medicaid
April 30, 2024
Insurance data: PBM reform has no material impact on premiums
April 24, 2024
3 Takeaways from POLITICO’s Health Care Summit
April 3, 2024
Four years later, Maryland board still hasn’t delivered for patients
February 12, 2024
Setting the Record Straight: Comparing U.S. drug prices to those in foreign countries hurts patients
February 7, 2024
ICYMI: When middlemen get in the way, it’s the patients who lose
December 5, 2023
Increased use of prior authorization in Medicaid is blocking access for patients
November 28, 2023
New analysis of patient access restrictions in the United Kingdom
November 21, 2023
ICYMI: WSJ — Same Drug, Two Prices: Why the Higher Price Prevails
November 15, 2023
ICYMI: 3 takeaways on the IRA’s unintended consequences from America’s Physician Groups’ 2023 annual fall conference
November 6, 2023
One year to Election Day: Four voter priorities to watch
November 6, 2023
ICYMI: Scott LaGanga and Matt Salo deliver a State of the Industry Report
October 25, 2023
ICYMI: Government watchdog report finds patients in Medicare Part D paid billions more for medicines than insurers and PBMs
September 28, 2023
Medicare Prescription Payment Plan will benefit patients if implemented correctly
September 21, 2023
New PhRMA ad exposes yet another way PBMs get between patients and their medicines
September 5, 2023
Manufacturers provided $42 billion in Medicaid discounts in 2021 alone
August 10, 2023
CMS should rethink proposed changes to the Medicaid Drug Rebate Program | PhRMA
August 1, 2023
Navigating the Patient Experience Survey: Protecting Lifelines to Access and Innovation
July 26, 2023
Three things to know from the latest Patient Experience Survey
July 20, 2023
ICYMI: PBM exec admits choosing profits over patients
June 2, 2023
New calculator demonstrates how improved adherence to anti-diabetic medicines can benefit people in Medicaid
May 25, 2023
4 key facts on medicine prices and spending
May 9, 2023
4 Things to know about PhRMA’s new 50-state poll
May 4, 2023
Americans want state policymakers to lower out-of-pocket costs
May 1, 2023
Three facts about health care spending
April 25, 2023
States can support access to medicine as COVID-19 Public Health Emergency ends
April 5, 2023
Arkansas puts patients first with new share the savings law
April 4, 2023
Key Trends: Patient experience data reveal how insurers and middlemen impose barriers in health care
March 29, 2023
Holding pharmacy benefit managers accountable
February 23, 2023
Stopping pharmacy benefit managers from “gaming the system”
February 22, 2023
Senate hearing to examine bipartisan reforms to rein in middlemen
February 16, 2023
Minnesota lawmakers are letting PBMs off the hook, and threatening patients’ access to medicines
January 31, 2023
ICYMI: PhRMA kicks off the year at the 2023 J.P. Morgan Health Care Conference
January 19, 2023
Study finds hepatitis C cure saved Medicaid $15 billion
January 5, 2023
In their own words: Insured Americans support policy reforms that address access and affordability concerns
December 14, 2022
In their own words: Financial barriers exacerbate access challenges for insured Americans
December 8, 2022
Putting Delaware patients first: Protecting Patient Assistance Programs
November 22, 2022
New data show how insurers and middlemen shift Rx costs onto patients
November 16, 2022
In their own words: Insured Americans struggle to navigate complex coverage
October 26, 2022
Many seniors are paying more for Part D medicines than their insurer
October 18, 2022
New comments outline ways to protect patients from health plans and PBMs who profit from patient assistance
October 7, 2022
Busting 3 Myths About Copay Coupons
October 5, 2022
Mental Illness Awareness Week – A time for reflection
October 3, 2022
A key fact the White House is reluctant to admit
September 27, 2022
A key fact the White House is reluctant to admit
September 27, 2022
Navigating the patient experience: Burdens and barriers standing between patients and their care
September 12, 2022
Making coupons count for patients at the pharmacy counter
August 25, 2022
Making coupons count for patients with HIV
August 8, 2022
The Senate’s latest price setting proposal will undermine: Our health care system
July 28, 2022
The Senate’s latest price setting proposal will undermine: Patient access to medicines
July 26, 2022
Survey Says: Prescription drug prices are not fueling inflation concerns for Americans
July 22, 2022
Putting patients first at the state level — A conversation with Mark Reisenauer, President of Astellas Pharma US
July 14, 2022
Patients win as West Virginia implements first-in-nation share the savings policy
July 8, 2022
3 things voters are concerned about when it comes to their health care coverage
July 7, 2022
Copay assistance is a lifeline for patients. So why are insurers blocking it?
June 29, 2022
CMS coverage decision restricts access to treatments for Alzheimer’s disease
June 22, 2022
Patients support state action requiring PBMs and insurers to share savings and cap costs for medicines
June 16, 2022
You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities
June 16, 2022
New poll shows voters sounding the alarm on health insurance companies and PBMs
June 6, 2022
PhRMA warns of the growing influence of middlemen over patient access and out-of-pocket costs for patients
May 31, 2022
PhRMA presents research at ISPOR 2022
May 26, 2022
Report finds PBMs are increasingly restricting patient access to medicines
May 25, 2022
ICYMI: PhRMA COO Lori Reilly spotlights efforts to improve health care in 2022 and beyond
May 9, 2022
Study finds insurance barriers disproportionately burden patients with chronic illness
May 4, 2022
What’s really happening when it comes to prescription drug costs
April 27, 2022
5 public opinion polling trends to watch
April 22, 2022
Analysis: States can help patients save nearly $1,000 annually on their medicines
April 21, 2022
New analysis confirms hospitals markup prices for oncology therapies
April 21, 2022
How standardized plans can improve patients’ access to medicines
April 18, 2022
The patient experience: Uncovering the barriers to care for insured Americans
March 28, 2022
Correcting the record: Putting medicine costs and spending in context
March 24, 2022
Sharing rebates can save Americans with diabetes 500 each year and improve adherence
March 16, 2022
If drug prices are growing below the rate of inflation, why are patients still feeling the sting at the pharmacy?
March 8, 2022
The patient experience: Insurance barriers continue to impede access to health care, especially among the country’s underserved
February 28, 2022
Medicaid 101: Three charts on access and spending
February 3, 2022
Government price setting won’t stop insurers from shifting costs to patients
February 2, 2022
New comments outline ways to counteract cost-shifting insurance trends
January 28, 2022
Patients need to pay less for their medicines. States can help.
January 26, 2022
It’s a new year, but sadly Congress is still pursuing flawed price setting policies
January 25, 2022
New poll of all 50 states and 435 Congressional Districts shows perils of so-called Medicare “negotiation”
January 25, 2022
New study finds more than half of brand medicine spending goes to the supply chain and others
January 7, 2022
Making medicines more affordable: Making insurance work like insurance
December 8, 2021
Insurance design barriers can impact patient adherence and can lead to poor health outcomes
November 23, 2021
What is missing in the current drug pricing plan
November 23, 2021
ICYMI: PhRMA CEO speaks at STAT Summit about government price setting
November 19, 2021
Making medicines more affordable: Sharing savings at the pharmacy counter
November 19, 2021
Three things to know about so-called Medicare negotiation polling
November 18, 2021
Making Medicines More Affordable: Making coupons count
November 5, 2021
What they are saying: Government price setting for medicines is not the answer
November 4, 2021
Four things to know from IQVIAs latest report
October 29, 2021
The patient experience: Insurance design hurdles lead to access issues for too many Americans
October 28, 2021
The patient experience: Out-of-pocket costs are driving patients affordability and access challenges
October 19, 2021
New report shows 3 in 10 Americans that have insurance still face a financial barrier to care
October 7, 2021
Industry leaders discuss the impact of the drug pricing debate
September 23, 2021
Five reasons tying VA prices to Medicare Part D misses the mark
September 22, 2021
America’s biopharmaceutical companies to Congress: Government “negotiation” is the wrong approach
September 15, 2021
ICYMI: Event spotlights how we can make Medicare work better for patients
August 4, 2021
The future of the rebate rule: Will policymakers stand with patients?
August 2, 2021
Celebrating Medicare’s 56th anniversary
July 30, 2021
3 factors impacting medication adherence for patients with diabetes
July 20, 2021
New reports shed light on key facts about medicines and affordability
June 8, 2021
Out-of-pocket trends in Medicare Part D show rising costs for seniors
May 24, 2021
Study finds nearly half of payers believe innovative contracts can lead to lower patient out-of-pocket costs
May 17, 2021
New data from insurers show detriments of copay accumulator adjustment programs
April 28, 2021
West Virginia becomes the first state to lower patient costs by sharing the savings
April 20, 2021
Getting the 340B program back on track in 2021
March 10, 2021
Nearly 40% of commercially insured patients face half their annual out-of-pocket expenses from just one health care encounter
March 2, 2021
Top five issues voters want addressed in the administration’s first 100 days
February 18, 2021
Insurers shift medicine costs to patients with severe chronic illnesses
February 1, 2021
Tennessee’s Medicaid demonstration fails patients
February 1, 2021
The latest misleading “poll” on drug pricing
January 28, 2021
The new Administration should reconsider a recent HHS rule that could negatively impact patient access and affordability
January 27, 2021
Election insights: Common ground areas to address Americans’ health care concerns
January 26, 2021
New insulin report highlights how incentives benefit middlemen, harm patients
January 22, 2021
Key facts: The final rebate rule will be a positive change for patients
January 19, 2021
New data show retail medicine prices fell in 2019
January 13, 2021
Election insights: Voter priorities in the states
December 17, 2020
Insights from the election: Meeting voters where they are on health care
December 15, 2020
Fact Check: How hospitals continue to drive health care spending
December 3, 2020
Final rebate rule represents right way to change Medicare
December 1, 2020
Accumulator adjustment programs lead to surprise out-of-pocket costs and nonadherence, analysis finds
November 19, 2020
Deep dive: The issues that drove the 2020 vote
November 13, 2020
Voters want to address the real drivers of health care costs for patients and the system
November 2, 2020
Study finds biopharmaceutical innovation is responsible for 35% of the increase in life expectancy from 1990 to 2015
October 21, 2020
Survey found insurance premiums grew faster than inflation in 2020
October 20, 2020
Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments
October 13, 2020
Growth in innovative, value-based contracts holds promise for the health system and for patients
September 24, 2020
Study finds middlemen excluded nearly 850 medicines from formularies this year
September 17, 2020
Recent administration actions undermine patient assistance programs
September 16, 2020
Innovative contracts drive access for patients and value for the system
September 9, 2020
Manufacturer cost-sharing assistance programs can save chronically ill patients hundreds to thousands of dollars annually
August 19, 2020
Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas
August 12, 2020
Commercial health plans transition from copays to coinsurance and deductibles has increased patient out-of-pocket costs
August 6, 2020
Four things to know about the IQVIA “Medicine Spending and Affordability in the U.S.” report
August 5, 2020
New data show commercially insured patients face increasingly high cost sharing for brand medicines
July 30, 2020
Payers subject 80% of new RA and MS patients to utilization management restrictions
July 22, 2020
PhRMA submits comments to CMS on Medicaid proposed rule
July 21, 2020
Study finds the pharmaceutical industry retains a smaller share of revenue than research-intensive industries
July 14, 2020
ICYMI: Pharmacy benefit managers increasingly exclude medicines from formularies, restricting patient access
June 1, 2020
New rule makes it harder for patients to lower their out-of-pocket costs
May 20, 2020
Retail medicine spending to remain stable share of overall health care spending through next decade
April 16, 2020
PhRMA comments on HHS proposed rule on manufacturer cost-sharing assistance and accumulator adjustment programs
March 3, 2020
Low-value health care costs $345B each year and provides little benefit
February 26, 2020
Addressing barriers that inhibit value-based contracts
February 21, 2020
Fact Check: HCCI analysis overstates medicine spending and prices
February 19, 2020
Cancer medicines cost twice as much at hospitals, study finds
January 21, 2020
Nearly 50% of brand medicine spending goes to the supply chain and others
January 9, 2020
New NHE data: Medicine prices declined, and hospitals were biggest driver of health care spending in 2018
December 6, 2019
Guest post: Value-based agreements can improve outcomes and even save patients money at the pharmacy counter
November 7, 2019
New data show how ICER’s value framework could prevent or delay access to treatments for Medicaid patients across the country
November 4, 2019
Guest post: Sharing discounts and rebates is the right thing to do
October 21, 2019
More evidence that medicine prices are growing at slowest rate in decades
October 4, 2019
The truth about the marketing and promotion of medicines
October 3, 2019
Survey shows out-of-pocket costs top health care concern for voters
October 2, 2019
Four reasons why the radical Pelosi Plan is the wrong approach
September 24, 2019
Hospitals make 9 times more than physicians’ offices on provider-administered medicines
September 10, 2019
Guest Post: Following my stroke, having access to ground-breaking medical innovation has never been more important
September 4, 2019
Three things to know about the Part D GAO report
August 16, 2019
Setting the record straight on international reference pricing
July 16, 2019
Four states adopt first-in-the-nation laws to protect patients from surprise insurer practices
July 15, 2019
New Let’s Talk About Cost TV ad asks: Why aren’t patients sharing in savings at the pharmacy counter?
July 9, 2019
Study finds hospitals continue to mark up medicines up to 500% of their cost
July 9, 2019
Three reasons why the latest Rx Savings Solutions analysis is misleading
July 2, 2019
5 Ways to improve ICER’s value assessment framework
June 20, 2019
Assessing value top of mind at ISPOR 2019
June 5, 2019
How the rebate rule would help reduce patients’ out-of-pocket costs
June 3, 2019
Ask About Adherence: OIG proposed rule to reform the rebate system could improve adherence
May 15, 2019
New study finds hospitals continue to push patients to costlier outpatient settings
May 13, 2019
4 Things to know about the IQVIA “Medicine Use and Spending” report
May 9, 2019
Six policy solutions to help patients afford their insulin
April 9, 2019
PhRMA comments on OIG proposed rule to reform the rebate system
April 8, 2019
340B continues to drive shift in site of care for physician-administered medicines to more expensive hospital settings
April 5, 2019
Five key facts about the market for insulins
April 1, 2019
Fact Check: How the Part B International Pricing Index model threatens patient access
March 29, 2019
OIG proposed rule could help strengthen the Part D market
March 28, 2019
Rebate rule would help ensure seniors with diabetes don’t pay more for their medicine than their insurer
March 25, 2019
New analysis shows 820,000 prescriptions would be in jeopardy if ICER’s value framework is used in Medicaid
March 20, 2019
The PBM story you haven’t heard: Hidden fees quadrupled in two years
March 20, 2019
OptumRX: Sharing rebates with patients is “worth it”
March 18, 2019
New data show how sharing negotiated discounts could save certain patients hundreds of dollars at the pharmacy counter
February 25, 2019
What you need to know about the new NHE health spending projections
February 22, 2019